About Multimodality NeuroMonitoring
NeuroSystems Products
New products in development
About NeuroSystems
Contact Us
NeuroSystems in the News
NeuroRegistry Online Database
In the pipeline...
     



NeuroSystems' R&D department continues to work closely with neurosurgeons and other physicians to develop innovative neuromonitoring products. The Company's first product, NeuroSystems 1™ is the result of over 5 years of R&D that culminated in the first clinically relevant multimodality neuromonitor. NeuroSystems 1 was also designed as a platform technology that will evolve to provide real-time remote patient monitoring as well as wireless connections to other monitors and multi-sensor probes.





 

TeleMonitor™
Real-time Remote Neuromonitoring

In intensive care environments, remote patient monitoring (sometimes referred to as Telemedicine) has been shown to lower mortality rates, complication rates, length of stay, and healthcare costs. In a pilot telemedicine study at Johns Hopkins, four critical care specialists remotely monitored a 10-bed surgical ICU. The results of that study were dramatic: death rates dropped by over 45 percent, complications by over 40 percent, length of stay over 30 percent, and costs by over 32 percent.

In a Neurosurgical ICU, access to the right information by the right specialist at the right time is critical to managing patients. The
TeleMonitor module will seamlessly integrate into NeuroSystems 1 to provide "anytime, anywhere" access to the same information that is available through the current NeuroSytems 1 monitor. Clinicians will be able to securely access NeuroSystems 1 through a secure Wifi-enabled PDA or through their own laptop or desktop computers.





 
 


Wireless ICU Monitoring
For the past 15+ years, ICP monitoring has been the standard of care in the Neuro ICU. With the current trend toward multimodality monitoring, devices that measure ICP, CBF, pBTO2, ETCO2, and other parameters will surely be present in the ICU. Since it is the relationships between and among the various monitored parameters that are of most interest to clinicians, these devices must ultimately be connected to a multimodality neuromonitor such as NeuroSystems 1. Making these connections wireless makes treating and transporting the patient less cumbersome and less error-prone.

NeuroSystems has developed prototypes demonstrating that virtually any existing monitor will be able to communicate with NeuroSystems 1.

Analog Wireless
Our analog wireless device will couple a small A/D converter with a wireless modem that uses 256-bit encryption to ensure patient data is secure and HIPAA compliant.

Digital Wireless
Our digital wireless device uses the same wireless modem and 256-bit encryption as our analog device to ensure secure, HIPAA compliant data transfer from the source device to NeuroSystems 1. This device will interface with any monitor that has an RS-232 or USB output.



 
     
Multisensor Probes
Multimodality neuromonitoring is unquestionably the future standard of care for traumatic brain injury and cerebrovascular disease. NeuroSystems multi-sensor probes will replace many of today's single-parameter sensors and monitors, making multimodality monitoring simple and efficient.

 
     








Copyright © 2003-2009 NeuroSystems, LLC. All rights reserved.
NeuroSystems and NeuroSystems 1 are trademarks of NeuroSystems, LLC.
Website by DE NOVO Medical Venture Marketing

Web server status